Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Infection and Rapid Transmission of SARS-CoV-2 in FerretsCell Host & Microbe, 2020-05, Vol.27 (5), p.704-709.e2 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2020.03.023 ;PMID: 32259477Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19Nature immunology, 2020-11, Vol.21 (11), p.1336-1345 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-020-0782-6 ;PMID: 32887977Full text available |
|
3 |
Material Type: Article
|
Animal models for COVID-19Nature (London), 2020-10, Vol.586 (7830), p.509-515 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2787-6 ;PMID: 32967005Full text available |
|
4 |
Material Type: Article
|
Rapid COVID-19 vaccine developmentScience, 2020-05, Vol.368 (6494) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/science.abb8923Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020-06, Vol.181 (7), p.1489-1501.e15 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.05.015 ;PMID: 32473127Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
SARS-CoV-2 vaccines in developmentNature (London), 2020-10, Vol.586 (7830), p.516-527 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2798-3 ;PMID: 32967006Full text available |
|
7 |
Material Type: Article
|
The COVID-19 vaccine development landscapeNature reviews. Drug discovery, 2020-05, Vol.19 (5), p.305-306 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00073-5 ;PMID: 32273591Full text available |
|
8 |
Material Type: Article
|
Maintaining Safety with SARS-CoV-2 VaccinesNew England Journal of Medicine, 2021-02, Vol.384 (7), p.643-649 [Peer Reviewed Journal]Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2035343 ;PMID: 33378605Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
The potential danger of suboptimal antibody responses in COVID-19Nature reviews. Immunology, 2020-06, Vol.20 (6), p.339-341 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-0321-6 ;PMID: 32317716Full text available |
|
10 |
Material Type: Article
|
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2New England Journal of Medicine, 2022-06, Vol.386 (23), p.2201-2212 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2118946 ;PMID: 35613036Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaquesNature (London), 2020-10, Vol.586 (7830), p.583-588 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2607-z ;PMID: 32731257Full text available |
|
12 |
Material Type: Article
|
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemicAsian Pacific journal of allergy and immunology, 2020-03, Vol.38 (1), p.1-9 [Peer Reviewed Journal]Copyright The Allergy and Immunology Society Mar 2020 ;ISSN: 0125-877X ;EISSN: 2228-8694 ;DOI: 10.12932/AP-200220-0772 ;PMID: 32105090Full text available |
|
13 |
Material Type: Article
|
Next-generation vaccine platforms for COVID-19Nature materials, 2020-08, Vol.19 (8), p.810-812 [Peer Reviewed Journal]This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2020. ;ISSN: 1476-1122 ;EISSN: 1476-4660 ;DOI: 10.1038/s41563-020-0746-0 ;PMID: 32704139Full text available |
|
14 |
Material Type: Article
|
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionNature immunology, 2021-01, Vol.22 (1), p.74-85 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-020-00808-x ;PMID: 32999467Full text available |
|
15 |
Material Type: Article
|
Prospects for a safe COVID-19 vaccineScience Translational Medicine, 2020-11, Vol.12 (568) [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.sciencemag.org/coronavirus-research-commentary-and-news?intcmp=ghd_cov ;DOI: 10.1126/scitranslmed.abe0948Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemicVaccine, 2020-10, Vol.38 (45), p.7002-7006 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;Attribution - NonCommercial ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2020.09.041 ;PMID: 32988688Full text available |
|
17 |
Material Type: Article
|
Convergent antibody responses to SARS-CoV-2 in convalescent individualsNature (London), 2020-08, Vol.584 (7821), p.437-442 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2456-9 ;PMID: 32555388Full text available |
|
18 |
Material Type: Article
|
Dissecting antibody-mediated protection against SARS-CoV-2Nature reviews. Immunology, 2020-07, Vol.20 (7), p.392-394 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-0359-5 ;PMID: 32514035Full text available |
|
19 |
Material Type: Article
|
A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2Cell, 2020-10, Vol.183 (1), p.169-184.e13 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.026 ;PMID: 32931734Digital Resources/Online E-Resources |
|
20 |
Material Type: Article
|
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsNature (London), 2020-10, Vol.586 (7830), p.589-593 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2639-4 ;PMID: 32785213Full text available |